Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Reasoning
Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Cite this ruling
CBP Ruling 968083 (3002100190): Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300210
The tariff classification of Actinase AS (CAS-9001-92-7) from Japan
The tariff classification of the SureScreen 6 Drug Multi Test (Catalog# MLT 406), and the One-Step Cannabis (THC) Test, from the United Kingdom
The tariff classification of heme-iron polypeptide (HIP) from Japan
The tariff classification of Precise One-Step Pregnancy Test and RapidVue 1-Step Pregnancy Test from Mexico
The applicability of duty exemption, under subheading 9801.00.10, HTSUS, to monoclonal antibodies processed in Belgium